Funding Opportunity: Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team
Stand Up to Cancer (SU2C) Canada, in partnership with the Canadian Cancer Society (CCS) and the Canadian Institutes of Health Research (CIHR) - Institute of Cancer Research (ICR) are pleased to announce a new funding opportunity: the Stand Up to Cancer Canada Metastatic Breast Cancer Dream Team, supported by CCS and CIHR.
A Webinar is planned to explain the application process and overall objectives of the call. Applicants can register by sending an email at email@example.com by July 9th, 2018. Details for the July 16, 2018 webinar (1-2 EST) will be provided in advance to interested applicants.
Letter of Intent due: August 10, 2018
Full Application due (invited): October 26, 2018
Anticipated Funding start date: Early 2019
The SU2C Canada Metastatic Breast Cancer (MBC) Dream Team represents a new, focused effort to implement advances in metastatic cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research "Metastatic Breast Cancer Dream Team". The most talented and promising researchers across Canadian institutions will be assembled into a pan-Canadian Dream Team, forming an optimal configuration of expertise needed to solve key problems in metastatic cancer and positively impact patients in the near future.
The successful MBC Dream Team will span multiple disciplines and utilize new tools of modern biology to attack research questions in a coordinated way. SU2C Canada, CCS and the CIHR believe that this unique Dream Team model will advance scientific research in the interests of both today’s cancer patients and those who may develop cancer in the future.
Full Details for this funding opportunity can be found at http://www.aacrcanada.ca/Pages/Funding-Opportunities.aspx